$ISDR
ISSUER DIRECT CORP Stock $isdr

$isdr Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000165495424005891 Filed on May 09, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$7.687M	$6.962M	$8.619M
YoY Change	-20.35%	-19.22%	62.99%
Cost Of Revenue	$1.785M	$1.721M	$1.829M
YoY Change	-23.59%	-5.9%	48.46%
Gross Profit	$5.902M	$5.241M	$6.790M
YoY Change	-19.32%	-22.81%	67.41%
Gross Profit Margin	76.78%	75.28%	78.78%
Selling, General & Admin	$4.134M	$3.915M	$4.713M
YoY Change	-4.15%	-16.93%	59.93%
% of Gross Profit	70.04%	74.7%	69.41%
Research & Development	$719.0K	$654.0K	$774.0K
YoY Change	35.15%	-15.5%	181.45%
% of Gross Profit	12.18%	12.48%	11.4%
Depreciation & Amortization	$770.0K	$770.0K	$736.0K
YoY Change	4.62%	4.62%	354.32%
% of Gross Profit	13.05%	14.69%	10.84%
Operating Expenses	$5.568M	$5.293M	$6.209M
YoY Change	0.0%	-14.75%	84.35%
Operating Profit	$334.0K	-$52.00K	$581.0K
YoY Change	-80.88%	-108.95%	-15.55%
Interest Expense	-$294.0K	$4.000K	-$238.0K
YoY Change	4.63%	-101.68%	-12000.0%
% of Operating Profit	-88.02%		-40.96%
Other Income/Expense, Net	$14.00K	$205.0K	$535.0K
YoY Change	-96.31%	-61.68%
Pretax Income	$54.00K	-$123.0K	-$192.0K
YoY Change	-97.07%	-35.94%	-127.83%
Income Tax	$47.00K	$16.00K	-$48.00K
% Of Pretax Income	87.04%
Net Earnings	$7.000K	-$139.0K	-$144.0K
YoY Change	-99.49%	-3.47%	-127.91%
Net Earnings / Revenue	0.09%	-2.0%	-1.67%
Basic Earnings Per Share	$0.00	-$0.04	-$0.04
Diluted Earnings Per Share	$0.00	-$0.04	-$0.04
COMMON SHARES
Basic Shares Outstanding	3.817M shares	3.815M shares	3.791M shares
Diluted Shares Outstanding	3.823M shares	3.821K shares	3.810M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.020M	$5.399M	$3.349M
YoY Change	-18.97%	61.21%	-86.2%
Cash & Equivalents	$4.020M	$5.399M	$3.349M
Short-Term Investments
Other Short-Term Assets	$1.331M	$1.286M	$1.416M
YoY Change	-16.66%	-9.18%	61.09%
Inventory
Prepaid Expenses
Receivables	$4.686M	$4.201M	$3.546M
Other Receivables	$202.0K	$213.0K	$139.0K
Total Short-Term Assets	$10.24M	$11.10M	$8.450M
YoY Change	-5.8%	31.35%	-70.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$435.0K	$472.0K	$594.0K
YoY Change	-22.74%	-20.54%	-14.66%
Goodwill	$21.93M	$21.93M	$16.12M
YoY Change	-2.54%	36.01%	152.85%
Intangibles	$28.13M	$28.81M	$59.05M
YoY Change	-8.86%	-51.22%	2424.37%
Long-Term Investments
YoY Change
Other Assets	$344.0K	$355.0K	$176.0K
YoY Change	-13.35%	101.7%	112.05%
Total Long-Term Assets	$52.58M	$53.27M	$56.15M
YoY Change	-5.67%	-5.12%	403.67%
TOTAL ASSETS
Total Short-Term Assets	$10.24M	$11.10M	$8.450M
Total Long-Term Assets	$52.58M	$53.27M	$56.15M
Total Assets	$62.82M	$64.37M	$64.60M
YoY Change	-5.69%	-0.35%	60.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.077M	$1.598M	$1.560M
YoY Change	-16.25%	2.44%	83.53%
Accrued Expenses	$1.983M	$2.033M	$2.344M
YoY Change	-16.47%	-13.27%	30.88%
Deferred Revenue
YoY Change
Short-Term Debt	$4.000M	$4.000M	$1.000M
YoY Change	100.0%	300.0%
Long-Term Debt Due	$4.000M	$4.000M
YoY Change
Total Short-Term Liabilities	$12.56M	$13.22M	$10.24M
YoY Change	3.93%	29.05%	61.92%
LONG-TERM LIABILITIES
Long-Term Debt	$13.92M	$14.92M	$18.92M
YoY Change	-22.24%	-21.16%
Other Long-Term Liabilities	$0.00	$0.00	$165.0K
YoY Change	-100.0%	-100.0%	-89.56%
Total Long-Term Liabilities	$13.92M	$14.92M	$19.09M
YoY Change	-22.24%	-21.84%	1107.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.56M	$13.22M	$10.24M
Total Long-Term Liabilities	$13.92M	$14.92M	$19.09M
Total Liabilities	$27.38M	$29.19M	$31.18M
YoY Change	-12.9%	-6.39%	287.59%
SHAREHOLDERS EQUITY
Retained Earnings	$11.80M	$11.80M	$11.02M
YoY Change	-4.72%	6.99%	13.07%
Common Stock	$4.000K	$4.000K	$4.000K
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$35.44M	$35.18M	$33.42M
YoY Change
Total Liabilities & Shareholders Equity	$62.82M	$64.37M	$64.60M
YoY Change	-5.69%	-0.35%	60.5%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$7.000K	-$139.0K	-$144.0K
YoY Change	-99.49%	-3.47%	-127.91%
Depreciation, Depletion And Amortization	$770.0K	$770.0K	$736.0K
YoY Change	4.62%	4.62%	354.32%
Cash From Operating Activities	-$190.0K	$986.0K	$272.0K
YoY Change	-110.98%	262.5%	-50.36%
INVESTING ACTIVITIES
Capital Expenditures	$155.0K	$16.00K	$5.000K
YoY Change	-10.4%	220.0%	-123.81%
Acquisitions		$0.00	-$350.0K
YoY Change		-100.0%
Other Investing Activities	$0.00	$0.00	$350.0K
YoY Change		-100.0%
Cash From Investing Activities	-$155.0K	-$261.0K	$345.0K
YoY Change	-10.4%	-175.65%	-1742.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$1.000M	$22.00M
YoY Change		-95.45%
Cash From Financing Activities	-1.000M	-$1.000M	-$2.100M
YoY Change		-52.38%	1593.55%
NET CHANGE
Cash From Operating Activities	-190.0K	$986.0K	$272.0K
Cash From Investing Activities	-155.0K	-$261.0K	$345.0K
Cash From Financing Activities	-1.000M	-$1.000M	-$2.100M
Net Change In Cash	-1.345M	-$275.0K	-$1.483M
YoY Change	-186.33%	-81.46%	-370.62%
FREE CASH FLOW
Cash From Operating Activities	-$190.0K	$986.0K	$272.0K
Capital Expenditures	$155.0K	$16.00K	$5.000K
Free Cash Flow	-$345.0K	$970.0K	$267.0K
YoY Change	-122.14%	263.3%	-53.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	282000	usd
CY2023Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	151000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	257000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	38000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	379000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	927000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0377	pure
CY2024Q1	isdr	Description Of Credit Agreement DescriptionOfCreditAgreement	the per annum interest rate of the Term Loan is variable based on the one-month secured overnight financing rate (“SOFR”) plus 2.35%, subject to a minimum SOFR of 2.00%. However, the Term Loan issued on the Closing Date has a per annum interest rate of 6.217%, which was fixed with respect to the entire principal amount as a result of an interest rate swap agreement entered into between the Company and Pinnacle on the Closing Date in accordance with the terms of the Credit Agreement
CY2023Q1	us-gaap	Line Of Credit Facility Periodic Payment Principal LineOfCreditFacilityPeriodicPaymentPrincipal	333333	usd
CY2023Q1	isdr	Maturity Date MaturityDate	December 20, 2028
CY2024Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	22880000	usd
CY2024Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	370000	usd
CY2024Q1	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	440000	usd
CY2024Q1	isdr	Payment For Other Expenss PaymentForOtherExpenss	370000	usd
CY2024Q1	isdr	Termination Of Unsecured Line Of Credit TerminationOfUnsecuredLineOfCredit	3000000	usd
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000843006
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3815212	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3817379	shares
CY2023Q4	isdr	Other Long Term Assets OtherLongTermAssets	184000	usd
CY2023Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	21000	usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	ISSUER DIRECT CORPORATION
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity File Number EntityFileNumber	1-10185
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1331503
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	One Glenwood Avenue
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1001
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Raleigh
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27603
CY2024Q1	dei	City Area Code CityAreaCode	919
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	481-4000
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001
CY2024Q1	dei	Trading Symbol TradingSymbol	ISDR
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3817379	shares
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5399000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5714000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1144000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1119000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4201000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4368000	usd
CY2024Q1	us-gaap	Income Tax Receivable IncomeTaxReceivable	213000	usd
CY2023Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	232000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1286000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1190000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	11099000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	11504000	usd
CY2024Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	3471000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	3424000	usd
CY2024Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	755000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	556000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	804000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	765000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	472000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	495000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	958000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1022000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	355000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	158000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	21927000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	21927000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10247000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9562000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	28805000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	29490000	usd
CY2024Q1	us-gaap	Assets Assets	64371000	usd
CY2023Q4	us-gaap	Assets Assets	65152000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1598000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1308000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2033000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1930000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	4000000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4000000	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5584000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5412000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	13215000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12650000	usd
CY2024Q1	isdr	Discount On Debt DiscountOnDebt	83000	usd
CY2023Q4	isdr	Discount On Debt DiscountOnDebt	87000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	14917000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15913000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	132000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	139000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	927000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1009000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	21000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	29191000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	29732000	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3817379	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3815212	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23464000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23531000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-83000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-49000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11795000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11934000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	35180000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	35420000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	64371000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	65152000	usd
CY2024Q1	us-gaap	Revenues Revenues	6962000	usd
CY2023Q1	us-gaap	Revenues Revenues	8619000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	1721000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1829000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	5241000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	6790000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1819000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2332000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2096000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2381000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	654000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	774000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	724000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	722000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	5293000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	6209000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-52000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	581000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-276000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-238000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	205000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-535000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-123000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-192000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-48000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-139000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-144000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3816	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3791	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3821	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3810	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-139000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-144000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-34000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-173000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-143000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	33223000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	337000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-144000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	33417000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	35420000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-67000	usd
CY2024Q1	isdr	Exercise Of Stock Awards Net Of Tax Amount ExerciseOfStockAwardsNetOfTaxAmount	0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-34000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-139000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	35180000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-139000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-144000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	770000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	736000	usd
CY2024Q1	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	282000	usd
CY2023Q1	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	151000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	26000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	-67000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	337000	usd
CY2024Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	4000	usd
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	0	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-126000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-719000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-208000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-250000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	290000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	186000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	187000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	187000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-238000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	986000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	272000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	350000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5000	usd
CY2024Q1	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	245000	usd
CY2023Q1	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-261000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	345000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1000000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	22000000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	19968000	usd
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	68000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2100000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-275000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1483000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5714000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4832000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-40000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5399000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3349000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	304000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	510000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	858000	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	65750	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	74250	shares
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	5584000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	5412000	usd
CY2024Q1	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	2793000	usd
CY2023Q1	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	2557000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	4201000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	4368000	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	142000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	130000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1119000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	745000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1144000	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Financial instruments and related items which potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents and accounts receivables. The Company places its cash and temporary cash investments with credit quality institutions. Such cash balances are currently in excess of the FDIC insurance limit of $250,000. To reduce its risk associated with the failure of such financial institutions, each quarter the Company evaluates the rating of each financial institution in which it holds deposits. As of March 31, 2024, the total amount exceeding such limit was $62,000. The Company also had cash-on-hand of $62,000 in Europe and $1,095,000 in Canada as of March 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The Company believes it did not have any financial instruments that could have potentially subjected us to significant concentrations of credit risk for any relevant period.</p>
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	62000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the allowance for doubtful accounts and the valuation of goodwill, intangible assets, deferred tax assets, and stock-based compensation. Actual results could differ from those estimates.</p>
CY2024Q1	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	245000	usd
CY2023Q1	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	0	usd
CY2024Q1	isdr	Amortization Included In Cost Of Revenues AmortizationIncludedInCostOfRevenues	46000	usd
CY2023Q1	isdr	Amortization Included In Cost Of Revenues AmortizationIncludedInCostOfRevenues	15000	usd
CY2024Q1	isdr	Finite Lived Intangible Assets Amortization Period Useful Life FiniteLivedIntangibleAssetsAmortizationPeriodUsefulLife	P15Y
CY2024Q1	us-gaap	Advertising Expense AdvertisingExpense	439000	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	462000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	90076	shares
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	331000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	26500	shares
CY2024Q1	isdr	Vested Number Of Year Restricted Stock VestedNumberOfYearRestrictedStock	P3Y
CY2024Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	14.86
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	60500	shares
CY2023Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	27.82
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	2167	shares
CY2024Q1	isdr	Share Based Compensation Arrangements By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageIntrinsicValue	28.24
CY2024Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	16000	usd
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	48000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1306000	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	76000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	76000	usd
CY2024Q1	us-gaap	Variable Lease Cost VariableLeaseCost	14000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	6000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	90000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	82000	usd
CY2024Q1	isdr	Weighted Average Non Cancelable Lease Term WeightedAverageNonCancelableLeaseTerm	P3Y9M
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	285000	usd
CY2024Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	390000	usd
CY2024Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	401000	usd
CY2024Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	412000	usd
CY2024Q1	us-gaap	Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths	1488000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	182000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1306000	usd
CY2024Q1	us-gaap	Revenues Revenues	6962000	usd
CY2024Q1	isdr	Concentration Risks Percentage1 ConcentrationRisksPercentage1	1	pure
CY2023Q1	us-gaap	Revenues Revenues	8619000	usd
CY2023Q1	isdr	Concentration Risks Percentage1 ConcentrationRisksPercentage1	1	pure
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	25000000	usd
CY2023Q1	isdr	Description Of Credit Agreement DescriptionOfCreditAgreement	(i) term loan facility in an aggregate principal amount of $20 million (the “Term Loan”), and (ii) revolving line of credit in an up to aggregate principal amount of $5 million (the “Revolving LOC”), subject to an 85% limit based on the current eligible accounts receivable (as defined in the Credit Agreement)
CY2024Q1	isdr	Interest Rate Swap Agreement InterestRateSwapAgreement	20000000	usd
CY2024Q1	isdr	Interest Rate Swap Agreemenrdescription InterestRateSwapAgreemenrdescription	the Company pays a fixed rate of interest at 6.217% and receives an average variable rate of SOFR + 2.35% adjusted monthly
CY2024Q1	us-gaap	Long Term Debt Weighted Average Interest Rate Over Time LongTermDebtWeightedAverageInterestRateOverTime	0.0767	pure
CY2024Q1	isdr	Other Long Term Assets OtherLongTermAssets	184000	usd
CY2024Q1	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	21000	usd
CY2024Q1	us-gaap	Other Income OtherIncome	205000	usd
CY2023Q1	us-gaap	Other Income OtherIncome	165000	usd

Files In Submission

Name	View Source	Status
0001654954-24-005891-index-headers.html	Edgar Link	pending
0001654954-24-005891-index.html	Edgar Link	pending
0001654954-24-005891.txt	Edgar Link	pending
0001654954-24-005891-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
isdr-20240331.xsd	Edgar Link	pending
isdr_10q.htm	Edgar Link	pending
isdr_10qimg1.jpg	Edgar Link	pending
isdr_10qimg3.jpg	Edgar Link	pending
isdr_ex311.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
isdr-20240331_cal.xml	Edgar Link	unprocessable
isdr-20240331_def.xml	Edgar Link	unprocessable
isdr-20240331_lab.xml	Edgar Link	unprocessable
isdr-20240331_pre.xml	Edgar Link	unprocessable
isdr_10q_htm.xml	Edgar Link	completed
isdr_ex312.htm	Edgar Link	pending
isdr_ex321.htm	Edgar Link	pending
isdr_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ISDR
ISSUER DIRECT CORP Stock $isdr

2024 Q2 Form 10-Q Financial Statement

#000165495424005891 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ISDR ISSUER DIRECT CORP Stock $isdr

2024 Q2 Form 10-Q Financial Statement

#000165495424005891 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ISDR
ISSUER DIRECT CORP Stock $isdr